IHMRI affiliation

Theme:Diagnostics and therapeutics

Publications and funding



  • Trad MA, Materne M, Reynolds G, Yao J, Miyakis S, Skyring T, Newton P. Carbapenem sparing in the management of post-transrectal prostate biopsy bacteraemia. ANZ J Surg 2019; 89(7-8): 935-939.
  • Dotel R, O’Sullivan MVN, Davis JS, Newton PJ, Gilbert GL. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in New South Wales, Australia, 2012-2017. Infect, Dis & Health 2019; 24: 134-140.
  • Van Hal SJ, Beukers AG, Timms VJ, Ellem JA, Taylor P, Maley MW, Newton PJ, Ferguson JK, Lee A, Chen SC-A, Sintchenko V. The relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation. J Antimicrob Chemother 2018; 76: 1487-1491.
  • Wright HL, Thomson RM, Reid AB, Carter R, Bartley PB, Newton P, Coulter
  • Rapidly growing mycobacteria associated with laparoscopic gastric banding, Australia, 2005-2011. Emerg Infect Dis 2014; 20: 1612-1619.
  • Bell SM, Pham JN, Newton PJ, Nguyen TT. Antibiotic Susceptibility Testing by the CDS Method: a manual for medical and veterinary laboratories 2013 7th ed, SEALS
  • Jayamaha J, Binns PL, Fennell M, Ferson MJ, Newton P, Tran T, Catton M, Robertson P, Rawlinson W. Laboratory diagnosis, molecular characteristics, epidemiological and clinical features of an outbreak of measles in a low incidence population in Australia. J Clin Virol 2012; 54: 168-173.
  • Schultz TR, Tapsall JW, White PA, Newton PJ. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones (letter to the editor). Antimicrob Agents and Chemother. 2000; 44:
  • Gosbell IB, Newton PJ, Sullivan EA. Survey of blood cultures from five community hospitals in south-western Sydney, Australia, 1993-1994. Aust NZ J Med 1999; 29: 684-692.
  • Newton PJ, Gosbell IB, Munro R. Clostridium beijerinckii endophthalmitis secondary to penetrating ocular injury. Pathology 1999; 31: 261-263.
  • Gosbell IB, Johnson CG, Newton PJ, Jelfs J. Clostridium tertium bacteraemia: 2 cases and review. Pathology 1996; 28: 70-73.
  • Wise KA, Newton PJ. Case report: a fatal case of Vibrio vulnificus septicaemia. Pathology 1992; 24: 121-122.
  • Brown MA, Farrell C, Newton PJ, Child RP. Case report: Thalidomide, pregnancy and renal failure. Med J Aust 1990; 152: 148-149.

Research Project Involvement:

  • 2017 – Present:  Coinvestigator Penicillin Susceptible Staphylococcus aureus (PSSA) Bacteraemia: Epidemiology and Treatment Outcomes
  • 2015 – Present:  Member of Australian Group on Antimicrobial Resistance (AGAR)
  • 2014 – Present:  Contributor to MERINO -1 and -2 RCTs ASID Clinical Research Network
  • 2013 – Present:  Associate Investigator NHMRC Grant APP 1079938  The Role of Occult Bacterial Cystitis in Refractory Urge Incontinence, Prof Kate Moore, UNSW


  • Australian Society for Microbiology (MASM) 1996 – Present
  • Australian Medical Association NSW branch 1989 – Present
  • Australasian Society for Infectious Diseases 2004 – Present
  • Australian Society for Antimicrobials 1999 – Present
  • International Society of chemotherapy 1999 – Present
  • Alliance for the Prudent Use of Antibiotics 1999 – Present
  • European Society of Clinical Microbiology and Infectious Diseases 2013 – Present
  • American Society for Microbiology from 2015 – Present

Other roles

  • Local Pathology Director for ISLHD and SNSWLHD NSW Health Pathology 
  • Clinical Senior Lecturer – School of Medicine University of Wollongong